Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.

Viruses - 1 Mar 2021

Grabowski Frederic, Preibisch Grzegorz, Giziński Stanisław, Kochańczyk Marek, Lipniacki Tomasz

Abstract excerpt

The novel SARS-CoV-2 Variant of Concern (VOC)-202012/01 (also known as B.1.1.7), first collected in United Kingdom on 20 September 2020, is a rapidly growing lineage that in January 2021 constituted 86% of all SARS-CoV-2 genomes sequenced in England. The VOC has been detected in 40 out of 46 countries that reported at least 50 genomes in January 2021. We have estimated that the replicative advantage of the VOC is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Motifs
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Phylogeny

Share to SARS-CoV-2

Share to SARS-CoV-2 and COVID-19 Research

Share to Spike Glycoprotein, Coronavirus

Share to Virus Replication

Source

Open in PubMed Open full text

Identifiers

PMID: 33804556
DOI: 10.3390/v13030392
PMCID: PMC8000749

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations.PMID 33804556Read ↗

Perspectives: SARS-CoV-2 Spike Convergent Evolution as a Guide to Explore Adaptive Advantage.Semantic proximity Read ↗

Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike MutationsSemantic proximity Read ↗

The Development of SARS-CoV-2 Variants: The Gene Makes the DiseaseSemantic proximity Read ↗

One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages.Semantic proximity Read ↗

A highly divergent SARS-CoV-2 lineage B.1.1 sample in a patient with long-term COVID-19Semantic proximity Read ↗

A highly divergent SARS-CoV-2 lineage B.1.1 sample in a patient with long-term COVID-19Semantic proximity Read ↗

SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and VaccinesSemantic proximity Read ↗

Novel SARS-CoV-2 variants: the pandemics within the pandemic.Semantic proximity Read ↗

Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants.Semantic proximity Read ↗

A review on evolution of emerging SARS-CoV-2 variants based on spike glycoprotein.Semantic proximity Read ↗

Rapid evolution of SARS-CoV-2 challenges human defenses.Semantic proximity Read ↗

Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.